Prospective phase II trial of alternating intravesical Bacillus Calmette-Guérin (BCG) and Interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: Preliminary results

✍ Scribed by S. Bazarbashi; M.A. Raja; A. El Sayed; A. Ezzat; E. Ibrahim; S. Kattan; A. Kardar; A. Peracha; E. Lindstedt; K. Hanash

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 93 KB
• Volume: 74
• Category: Article
• ISSN: 0022-4790
• DOI: 10.1002/1096-9098(200007)74:3<181::aid-jso3>3.0.co;2-f